Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK: Cytyc's Novasure awaits NICE (National Institute for Clinical Excellence) verdict

This article was originally published in Clinica

Executive Summary

Cytyc has launched its Novasure radiofrequency endometrial ablation system in the UK, as part of plans to expand its EU market coverage of the technology. The impedance-controlled bipolar ablation system used to treat menorrhagia (heavy menstrual bleeding) was CE-marked in 2002, but Novasure's real success in the UK is set to hinge on the current assessment of the technology by the National Institute for Clinical Excellence (NICE).





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts